Location History:
- Kongju-si, KR (2009 - 2012)
- Daejeon, KR (2010 - 2012)
Company Filing History:
7 out of 16 
2 out of 624 
Years Active: 2009-2012
Title: Seon-Yle Ko: Innovator in Osteoporosis Treatment
Introduction
Seon-Yle Ko is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical compositions, particularly in the prevention and treatment of osteoporosis. With a total of 7 patents to his name, his work has the potential to impact many lives.
Latest Patents
Among his latest patents is a herbal mixture extract of Rehmanniae Radix Preparata and Acanthopanacis Cortex. This composition is designed for the prevention and treatment of osteoporosis. The invention enhances the expression of osteoprotegerin (OPG) in osteoblasts and effectively inhibits the generation and activation of osteoclasts. This makes it a promising option for those at risk of osteoporosis. Another notable patent involves a pharmaceutical composition for preventing and treating metabolic bone diseases, which contains alpha-arylmethoxyacrylate derivatives. This specific derivative, or its pharmacologically acceptable salt or solvate, is aimed at addressing metabolic bone diseases.
Career Highlights
Seon-Yle Ko has worked with notable organizations such as Oscotec Inc. and the Korea Research Institute of Chemical Technology. His experience in these institutions has allowed him to develop innovative solutions in the field of bone health.
Collaborations
He has collaborated with esteemed colleagues, including Jung-Keun Kim and Se-Won Kim, to further advance his research and inventions.
Conclusion
Seon-Yle Ko's contributions to the field of osteoporosis treatment through his innovative patents highlight his dedication to improving health outcomes. His work continues to pave the way for advancements in pharmaceutical compositions aimed at bone health.